Sara Nilsson

Sara Nilsson is currently a Scientist, Bioanalysis at Hansa Biopharma since September 2021. Prior to this, Sara worked as a Researcher at Lund University, focusing on complement deficiencies in Systemic Lupus Erythematosus and citrullination effects on complement proteins in rheumatoid arthritis. Sara also explored complement inhibitor C4b-binding protein in islet amyloid polypeptide-induced cytotoxicity in beta cells during parental leave. With a background in Molecular Biology, Sara has a Doctor of Philosophy (PhD) in Medicine from Lund University.